You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

keytruda

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Melanoma (Skin) Trial in Omsk, Saint Petersburg (BCD-201, Keytruda)

Recruiting
  • Melanoma (Skin)
  • Omsk, Russian Federation
  • +2 more
Aug 1, 2023

Biliary Cancer, Bile Duct Cancer, Cancer of the Bile Duct Trial run by the National Cancer Institute (NCI) (oxaliplatin,

Not yet recruiting
  • Biliary Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
May 13, 2023

Melanoma, Non Small Cell Lung Cancer Trial in Moscow, Omsk, Saint Petersburg (BCD-201, Keytruda)

Active, not recruiting
  • Melanoma
  • Non Small Cell Lung Cancer
  • Moscow, Russian Federation
  • +2 more
Feb 13, 2023

Gastric Cancer, Hepatocellular Carcinoma Trial in Beverly Hills, Los Angeles, Torrance (Telatinib, Keytruda)

Recruiting
  • Gastric Cancer
  • Hepatocellular Carcinoma
  • Beverly Hills, California
  • +3 more
Sep 1, 2022

Solid Tumor, Melanoma Trial in Beijing (OH2 injection, Keytruda)

Recruiting
  • Solid Tumor
  • Melanoma
  • OH2 injection
  • Keytruda
  • Beijing, Beijing, China
    Peking University Cancer Hospital
Apr 1, 2022

Lenvatinib Combined Anti-PD1 Antibody for Advanced

Completed
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Second Affiliated Hospital of Guangzhou Medical University
Jul 8, 2022

Axitinib Therapy Management Study

Withdrawn
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer Inc.
Mar 25, 2022

Neuroblastoma Trial in Houston (iC9-GD2 T Cells - frozen, iC9-GD2 T Cells - fresh, Cytoxan)

Active, not recruiting
  • Neuroblastoma
  • iC9-GD2 T Cells - frozen
  • +5 more
  • Houston, Texas
  • +1 more
Jan 4, 2023

Tumors Trial in Chile, United States (VIP152 (BAY 1251152), VIP152 (BAY 1251152) 30 mg, Keytruda)

Recruiting
  • Neoplasms
  • VIP152 (BAY 1251152)
  • +3 more
  • Springdale, Arkansas
  • +12 more
Mar 24, 2022

Head Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma, HPV-Related Carcinoma Trial in United States (CUE-101,

Recruiting
  • Head and Neck Cancer
  • +2 more
  • Tucson, Arizona
  • +16 more
Nov 15, 2022

Metastatic Solid Tumor Cancer, Recurrent Head Neck Cancer Trial in Houston (Ad-P53, Xeloda, Keytruda)

Terminated
  • Metastatic Solid Tumor Cancer
  • Recurrent Head and Neck Cancer
  • Houston, Texas
    MD Anderson Cancer Center
May 30, 2020